)
Visual
test
Observe Medical
Observe Medical (OBSRV) investor relations material
Observe Medical Trading update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Trading update summary25 Mar, 2026
Strategic vision and business model
Focus on developing proprietary products under own trademarks and building a scalable Nordic medtech platform with global reach, emphasizing profitable growth, product development, and regulatory performance.
Commercialization and portfolio development leverage a Nordic ecosystem for innovation and global distribution.
Aims to improve patient welfare, health economics, and data accuracy through advanced solutions.
Product development and innovation
Successfully launched UnoMeter Safeti Max, now commercially available after positive clinical study and CE certification.
Safeti Max incorporates SafeCoat technology, with three patents, one pending, and UnoSafeCoat trademark registered.
Portfolio expanded from two/three to seven products in 1.5 years, including new front-mounted UnoMeter and US-style products.
Sippi remains a strategic focus, targeting ICU digital measurement market, with CE certification and market launch planned when portfolio traction is sufficient.
Financial and trading update
Achieved 80% year-on-year sales growth, reaching NOK 22 million in the last twelve months, with Q1 2026 sales estimated at NOK 7.6 million, a 60% YoY increase.
Quarterly order intake grew 73% to NOK 8.5 million, reflecting improved market penetration and activity.
UnoMeter Safeti Plus is a key driver of sales momentum.
On track to become cash positive within the year.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Observe Medical
- Growth driven by innovative medtech products, market expansion, and financial restructuring.OBSRV
Company presentation25 Mar 2026 - Strong UnoMeter growth, major debt reduction, and Biim Ultrasound impairment define FY 2025.OBSRVQ4 202527 Feb 2026
- Revenue up 10% to NOK 13.1M, margin 38.2%, net loss narrowed, global growth initiatives ongoing.OBSRVQ2 20243 Feb 2026
- Strong product launches and global expansion drive growth in urine output measurement markets.OBSRVTrading update24 Nov 2025
- Strong order growth, global reach, and innovation drive expansion in a NOK 4 billion market.OBSRVTrading Update7 Oct 2025
- Strong UnoMeter sales and debt restructuring boost liquidity, but going concern risk persists.OBSRVQ2 202522 Aug 2025
- Scaling innovative urine measurement solutions globally while restructuring for profitable growth.OBSRVCompany Presentation12 Jun 2025
- Revenue fell and losses deepened in 2024, but UnoMeter Safeti Plus offers growth potential.OBSRVQ4 20246 Jun 2025
Next Observe Medical earnings date
Q2 202625 Aug, 2026
Observe Medical
Next Observe Medical earnings date
Q2 202625 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage